Physical dependence on nicotine gum: effect of duration of use
- PMID: 7870986
- DOI: 10.1007/BF02253535
Physical dependence on nicotine gum: effect of duration of use
Abstract
This study examined whether longer duration on nicotine gum promoted dependence on nicotine gum. Subjects (N = 128) answering an advertisement for smoking cessation research and wanting to quit smoking cigarettes were randomly assigned to 1- or 3-month duration of nicotine gum use. Assessments were made weekly for smoking status (with biochemical verification) and withdrawal symptoms during and at the end of treatment. Follow-up was conducted at 1, 6 and 12 months to provide exploratory data on treatment outcome. The results showed minimal nicotine gum withdrawal symptoms after gum cessation with virtually no difference in gum withdrawal between the 1- and 3-month groups. Withdrawal symptoms from the nicotine gum included difficulty with concentration, increased variability on a reaction time task, and decreased vigor. The results also showed that continuous use of the gum at 1 year was observed in 1.5% of subjects and estimated to be as high as 14%. Finally, the 3-month group experienced a 2-fold increase in abstinence compared to the 1-month group, although this difference was not statistically significant. We conclude that there is minimal physical dependence on nicotine gum.
Similar articles
-
Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study.JAMA. 1984 Nov 23-30;252(20):2835-8. JAMA. 1984. PMID: 6387207 Clinical Trial.
-
Effect of instructions and nicotine on smoking cessation, withdrawal symptoms and self-administration of nicotine gum.Psychopharmacology (Berl). 1989;99(4):486-91. doi: 10.1007/BF00589896. Psychopharmacology (Berl). 1989. PMID: 2594915 Clinical Trial.
-
Effects of nicotine gum dose by level of nicotine dependence.Nicotine Tob Res. 2000 Feb;2(1):53-63. doi: 10.1080/14622200050011303. Nicotine Tob Res. 2000. PMID: 11072441 Clinical Trial.
-
Dependence potential and abuse liability of nicotine replacement therapies.Biomed Pharmacother. 1989;43(1):11-7. doi: 10.1016/0753-3322(89)90185-6. Biomed Pharmacother. 1989. PMID: 2659095 Review.
-
Clinical use of nicotine chewing-gum.Br Med J. 1980 Jun 28;280(6231):1599-602. doi: 10.1136/bmj.280.6231.1599. Br Med J. 1980. PMID: 7000247 Free PMC article. Review.
Cited by
-
Dependence on tobacco and nicotine products: a case for product-specific assessment.Nicotine Tob Res. 2012 Nov;14(11):1382-90. doi: 10.1093/ntr/nts007. Epub 2012 Mar 29. Nicotine Tob Res. 2012. PMID: 22459798 Free PMC article.
-
Reduced nicotine content cigarettes and nicotine patch.Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1015-24. doi: 10.1158/1055-9965.EPI-12-1439. Epub 2013 Apr 19. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23603206 Free PMC article. Clinical Trial.
-
Subjective effects of the nicotine lozenge: assessment of abuse liability.Psychopharmacology (Berl). 2003 Apr;167(1):20-7. doi: 10.1007/s00213-002-1361-2. Epub 2003 Mar 4. Psychopharmacology (Berl). 2003. PMID: 12616334 Clinical Trial.
-
The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.Clin Pharmacokinet. 2001;40(9):661-84. doi: 10.2165/00003088-200140090-00003. Clin Pharmacokinet. 2001. PMID: 11605715 Review.
-
Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.Addiction. 2010 Feb;105(2):343-55. doi: 10.1111/j.1360-0443.2009.02780.x. Addiction. 2010. PMID: 20078491 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical